Share on StockTwits

Shares of Carillion plc (LON:CLLN) have earned a consensus recommendation of “Buy” from the fifteen brokerages that are presently covering the stock, reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is GBX 371.82 ($6.22).

A number of research firms have recently commented on CLLN. Analysts at Oriel Securities Ltd initiated coverage on shares of Carillion plc in a research note on Thursday. They set a “buy” rating and a GBX 402 ($6.72) price target on the stock. Separately, analysts at Liberum Capital reiterated a “buy” rating on shares of Carillion plc in a research note on Wednesday. They now have a GBX 300 ($5.02) price target on the stock. Finally, analysts at Numis Securities Ltd reiterated a “hold” rating on shares of Carillion plc in a research note on Monday, August 18th. They now have a GBX 315 ($5.27) price target on the stock.

Shares of Carillion plc (LON:CLLN) opened at 338.90 on Wednesday. Carillion plc has a one year low of GBX 269.07 and a one year high of GBX 396.537. The stock’s 50-day moving average is GBX 334.7 and its 200-day moving average is GBX 351.0. The company’s market cap is £1.458 billion.

The company also recently declared a dividend, which is scheduled for Wednesday, November 5th. Stockholders of record on Wednesday, September 3rd will be given a dividend of GBX 5.60 ($0.09) per share. This represents a yield of 1.62%. The ex-dividend date of this dividend is Wednesday, September 3rd.

Carillion plc is an integrated support services company, with a portfolio of public private partnership projects and construction capabilities.

Receive News & Ratings for Carillion plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carillion plc and related companies with Analyst Ratings Network's FREE daily email newsletter.